IFP Advisors’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

IFP Advisors’s Portfolio CANF Stock Details CANF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1	Closed	-$3K	–	3545
2018 Q3	$3K	Hold	1	–	–	﹤0.01%	3387
2018 Q2	$2K	Buy	+1	New	+$3.99K	﹤0.01%	3565
2016 Q4	–	Hold	0	–	-$3K	–	3984
2016 Q3	–	Sell	-3	Closed	-$20.9K	–	3431
2016 Q2	$23K	Buy	+3	New	+$25.4K	﹤0.01%	2251
2016 Q1	–	Sell	-1	Closed	-$4K	–	2496
2015 Q4	$4K	Buy	+1	New	+$10.1K	﹤0.01%	3058

Other funds holding CANF

TAM

Taylor Asset Management Toronto, Ontario, Canada $154M AUM 10.32% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Advisornet Financial Minnetonka, Minnesota $2.19B AUM 21.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

IFP Advisors's CANF Position: Q4 2018 in Review

IFP Advisors sold out of Can-Fite BioPharma American Depositary Shares (CANF) in Q4 2018, closing a stake of 1 share — an estimated $3K sold.

IFP Advisors first reported a position in CANF in Q4 2015 and held it in 4 quarters. The position peaked at $23K in Q2 2016. 7 funds tracked by Wall St. Rank hold CANF as of Q4 2018.

IFP Advisors reported no remaining Can-Fite BioPharma American Depositary Shares position as of Q4 2018 after selling out during the quarter.
IFP Advisors sold 1 Can-Fite BioPharma American Depositary Shares share in Q4 2018, an estimated $3K.
IFP Advisors first reported a position in Can-Fite BioPharma American Depositary Shares in Q4 2015 and held it in 4 quarters.
IFP Advisors's Can-Fite BioPharma American Depositary Shares position peaked at $23K in Q2 2016.
7 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q4 2018.

Based on IFP Advisors's 13F filing for Q4 2018, filed 23 Jan 2019.